Post by FDA

The FDA is moving forward on men's health by encouraging sponsors of approved testosterone replacement therapy products to explore a potential new use—treating low libido in men with idiopathic hypogonadism. https://lnkd.in/e-5v25h3 Emerging data suggest this may help men experiencing symptoms that affect quality of life. The agency is committed to advancing treatment options while maintaining rigorous safety and effectiveness standards.

Video Content